AVADEL PHARMACEUTICALS PLC's ticker is and the CUSIP is 05337M904. A total of 2 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,545,000 | -73.5% | 150,000 | -57.6% | 0.01% | -73.7% |
| Q2 2023 | $5,832,272 | +113.9% | 353,900 | +18.9% | 0.02% | +90.0% |
| Q1 2023 | $2,726,016 | +13.3% | 297,600 | -11.4% | 0.01% | +66.7% |
| Q4 2022 | $2,405,044 | +86.6% | 335,900 | +30.6% | 0.01% | +100.0% |
| Q3 2022 | $1,289,000 | +467.8% | 257,200 | +176.3% | 0.00% | – |
| Q2 2022 | $227,000 | -57.3% | 93,100 | +19.8% | 0.00% | -100.0% |
| Q1 2022 | $531,000 | -47.5% | 77,700 | -37.9% | 0.00% | 0.0% |
| Q4 2021 | $1,011,000 | +120.3% | 125,100 | +167.3% | 0.00% | – |
| Q3 2021 | $459,000 | -80.6% | 46,800 | -86.7% | 0.00% | -100.0% |
| Q2 2021 | $2,371,000 | -52.7% | 352,300 | -36.4% | 0.00% | -57.1% |
| Q1 2021 | $5,009,000 | +1762.1% | 554,100 | +1274.9% | 0.01% | – |
| Q4 2020 | $269,000 | +224.1% | 40,300 | +144.2% | 0.00% | – |
| Q3 2020 | $83,000 | -97.9% | 16,500 | -96.6% | 0.00% | -100.0% |
| Q2 2020 | $3,895,000 | -18.8% | 482,000 | -20.2% | 0.02% | -53.8% |
| Q1 2020 | $4,798,000 | +107.0% | 604,300 | +96.8% | 0.04% | +143.8% |
| Q4 2019 | $2,318,000 | +568.0% | 307,000 | +268.1% | 0.02% | +433.3% |
| Q3 2019 | $347,000 | +1408.7% | 83,400 | +942.5% | 0.00% | – |
| Q2 2019 | $23,000 | -92.7% | 8,000 | -84.4% | 0.00% | -100.0% |
| Q2 2018 | $314,000 | -28.6% | 51,300 | -15.1% | 0.00% | -25.0% |
| Q1 2018 | $440,000 | +5400.0% | 60,400 | +5940.0% | 0.00% | – |
| Q4 2017 | $8,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 335,900 | $2,405,044 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 39,700 | $284 | 0.00% |
| JANE STREET GROUP, LLC | 91,700 | $656,572 | 0.00% |